Back to search

Netherlands· NL-d54fb5e0f670

Lafamme 1 mg/2 mg, omhulde tabletten

A dienogest und estrogen product containing dienogest + estradiolvaleraat, registered in Netherlands by Bayer B.V.. The same ATC class is registered in 5 of our 19 countries.

ATC G03FA15

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLafamme 1 mg/2 mg, omhulde tablettenATCG03FA15REGISTER NO.NL-d54fb5e0f670PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Dienogest und estrogen is registered in 5 of 19 countries.

Countries holding a registration under ATC G03FA15 (dienogest und estrogen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose

Dienogest und estrogen · ATC G03FA15

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DIENOGEST + ESTRADIOLVALERAAT
Manufacturer
Bayer B.V.
Country
Netherlands (NL)
ATC code
G03FA15
ATC class
Dienogest und Estrogen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    32405

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dienogest und estrogen in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dienogest und estrogen products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Velbienne
  • Belgium · Laclimella, Velbienne
  • Czechia · Audera, Velbienne
  • Germany · Ariora, Dielera
  • Estonia · Velbienne
  • Spain · Velbienne
  • Italy · Damsel, Paudien
  • Lithuania · Velbienne
  • Luxembourg · Laclimella, Velbienne
  • Latvia · Velbienne
  • Poland · Juvinelle, Velbienne Mini
  • Portugal · Clifemme
  • Sweden · Audera, Idilla
  • Slovakia · Velbienne

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ef5bd096-e8bc-47e7-9924-94912ad8ad9a
GET /v1/drugs/ef5bd096-e8bc-47e7-9924-94912ad8ad9a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Omhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h32405_smpc.pdf",
  "strength": null,
  "atc_label": "Dienogest And Estrogen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg32405",
  "excipients": [
    "CALCIUMCARBONAAT (E 170)",
    "CARNAUBAWAS (E 903)",
    "GLUCOSE, VLOEIBAAR",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 35000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "POVIDON K 25 (E 1201)",
    "SACCHAROSE",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "DIENOGEST",
    "ESTRADIOLVALERAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h32405.pdf",
  "authorised_at": "2005/05/02",
  "procedure_number": "NL/H/0652/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "32405",
  "additional_monitoring": "N"
}

See everything about dienogest und estrogen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.